|
|
|
|
|
|
|
|
Note: the NCCN website requires registration/password but is free. It is an excellent resource for ovarian cancer(s) as well as genetic syndrome guidelines.
Page 4 indicates changes over prior guidelines.
There are some substantial changes some of which include: extent of primary debulking both in early/advanced stages; specific attention to mucinous cell type (appendectomy) to rule in/out GI primary/occult ovarian mets; consideration of using chemo sensitivity/resistance tumour assay testing; management of drug reactions;
Ovarian Cancer
* Epithelial Ovarian Cancer (including Fallopian Tube Cancer and Primary Peritoneal Cancer)
* Borderline Epithelial Ovarian Cancer (Low Malignant Potential)
* Less Common Ovarian Histologies)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.